Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study.
Eur J Cancer. 2022 Apr;165:13-24. doi: 10.1016/j.ejca.2022.01.005. Epub 2022 Feb 1.
Eur J Cancer. 2022.
PMID: 35189537
Free PMC article.
Seroprevalence of SARS-CoV-2 among the staff and patients of a French cancer centre after first lockdown: The canSEROcov study.
Ladoire S, Goussot V, Redersdorff E, Cueff A, Ballot E, Truntzer C, Ayati S, Bengrine-Lefevre L, Bremaud N, Coudert B, Desmoulins I, Favier L, Fraisse C, Fumet JD, Hanu R, Hennequin A, Hervieu A, Ilie S, Kaderbhai C, Lagrange A, Martin N, Mazilu I, Mayeur D, Palmier R, Simonet-Lamm AL, Vincent J, Zanetta S, Arnould L, Coutant C, Bertaut A, Ghiringhelli F.
Ladoire S, et al. Among authors: palmier r.
Eur J Cancer. 2021 May;148:359-370. doi: 10.1016/j.ejca.2021.02.027. Epub 2021 Feb 27.
Eur J Cancer. 2021.
PMID: 33780664
Free PMC article.
Item in Clipboard
Safety and Efficacy of Gemcitabine, Docetaxel, Capecitabine, Cisplatin as Second-line Therapy for Advanced Pancreatic Cancer After FOLFIRINOX.
Fumet JD, Vincent J, Bengrine L, Hennequin A, Granconato L, Palmier R, Ghiringhelli F.
Fumet JD, et al. Among authors: palmier r.
Anticancer Res. 2020 Jul;40(7):4011-4015. doi: 10.21873/anticanres.14395.
Anticancer Res. 2020.
PMID: 32620645
Item in Clipboard
Phase I Dose-Escalation Trial of an Innovative Chemotherapy Regimen Combining a Fractionated Dose of Irinotecan Plus Bevacizumab, Oxaliplatin, 5-Fluorouracil, and Folinic Acid (bFOLFIRINOX-3) in Chemorefractory Metastatic Colorectal Cancer.
Bellio H, Bertaut A, Hervieu A, Zanetta S, Hennequin A, Vincent J, Palmier R, Bengrine-Lefevre L, Ghiringhelli F, Fumet JD.
Bellio H, et al. Among authors: palmier r.
Cancers (Basel). 2021 Oct 30;13(21):5472. doi: 10.3390/cancers13215472.
Cancers (Basel). 2021.
PMID: 34771635
Free PMC article.
Item in Clipboard
Association of 5-FU Therapeutic Drug Monitoring to DPD Phenotype Assessment May Reduce 5-FU Under-Exposure.
Dolat M, Macaire P, Goirand F, Vincent J, Hennequin A, Palmier R, Bengrine-Lefevre L, Ghiringhelli F, Royer B, Schmitt A.
Dolat M, et al. Among authors: palmier r.
Pharmaceuticals (Basel). 2020 Nov 23;13(11):416. doi: 10.3390/ph13110416.
Pharmaceuticals (Basel). 2020.
PMID: 33238487
Free PMC article.
Item in Clipboard
A colonoscopy quality improvement intervention in an endoscopy unit.
Palmier R, Degand T, Aho S, Lepage C, Facy O, Michiels C, Manfredi S.
Palmier R, et al.
Sci Rep. 2022 Jan 17;12(1):817. doi: 10.1038/s41598-022-04786-y.
Sci Rep. 2022.
PMID: 35039559
Free PMC article.
Item in Clipboard
FOLFIRI-bevacizumab as a second-line treatment for advanced biliary tract cancer after gemcitabine-based chemotherapy.
Roussot N, Vincent J, Palmier R, Constantin G, Bengrine L, Fumet JD, Ghiringhelli F.
Roussot N, et al. Among authors: palmier r.
Front Oncol. 2023 Nov 30;13:1293670. doi: 10.3389/fonc.2023.1293670. eCollection 2023.
Front Oncol. 2023.
PMID: 38098503
Free PMC article.
Item in Clipboard
Cite
Cite